GB610570A - Antibiotics - Google Patents
AntibioticsInfo
- Publication number
- GB610570A GB610570A GB10144/46A GB1014446A GB610570A GB 610570 A GB610570 A GB 610570A GB 10144/46 A GB10144/46 A GB 10144/46A GB 1014446 A GB1014446 A GB 1014446A GB 610570 A GB610570 A GB 610570A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- centrifuged
- aqueous
- solids
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 9
- 239000007787 solid Substances 0.000 abstract 7
- 239000000284 extract Substances 0.000 abstract 6
- 238000000605 extraction Methods 0.000 abstract 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 5
- 230000003115 biocidal effect Effects 0.000 abstract 5
- 235000011149 sulphuric acid Nutrition 0.000 abstract 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical class C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 4
- 239000000126 substance Substances 0.000 abstract 4
- 239000001117 sulphuric acid Substances 0.000 abstract 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
- 241000187392 Streptomyces griseus Species 0.000 abstract 3
- 239000011260 aqueous acid Substances 0.000 abstract 3
- 239000007788 liquid Substances 0.000 abstract 3
- 235000013372 meat Nutrition 0.000 abstract 3
- 239000002002 slurry Substances 0.000 abstract 3
- 229960005322 streptomycin Drugs 0.000 abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 235000015165 citric acid Nutrition 0.000 abstract 2
- 239000012153 distilled water Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 239000002609 medium Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000013049 sediment Substances 0.000 abstract 2
- 238000001179 sorption measurement Methods 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- 239000005909 Kieselgur Substances 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- JKNZUZCGFROMAZ-UHFFFAOYSA-L [Ag+2].[O-]S([O-])(=O)=O Chemical compound [Ag+2].[O-]S([O-])(=O)=O JKNZUZCGFROMAZ-UHFFFAOYSA-L 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- ZGLIQORZYPZFPW-UHFFFAOYSA-K azanium;azane;chromium(3+);tetrathiocyanate Chemical compound N.N.[NH4+].[Cr+3].[S-]C#N.[S-]C#N.[S-]C#N.[S-]C#N ZGLIQORZYPZFPW-UHFFFAOYSA-K 0.000 abstract 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 abstract 1
- 229910001863 barium hydroxide Inorganic materials 0.000 abstract 1
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
- 239000008121 dextrose Substances 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 239000012263 liquid product Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000012054 meals Nutrition 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 abstract 1
- 235000021178 picnic Nutrition 0.000 abstract 1
- 229940075930 picrate Drugs 0.000 abstract 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 230000000630 rising effect Effects 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
Landscapes
- Compounds Of Unknown Constitution (AREA)
Abstract
A streptomycin-like ether insoluble antibiotic substance is produced by subjecting the solids of a culture of Actinomyces griseus that has produced streptomycin to extraction with an aqueous acid, and, if desired, recovering the antibiotic substance in the extract. The extraction of the solids may be effected after or before their separation from the culture liquid, or at both stages. Thus the solids may first be separated, e.g. by centrifuging or filtration, and then extracted with an aqueous acid. Alternatively the whole culture, preferably after substantially maximum streptomycin production has been attained, may be acidified and the solid and liquid components intimately contacted, whereby the antibiotic substance in the solids is extracted into the streptomycin-containing liquid and enhances its activity. The residual solids from this latter process may, if desired, be subjected to a further treatment with an aqueous acid. The acid used may be inorganic or organic, sulphuric and citric acids being preferred, and the extraction may be effected at various pH values, e.g. 5.6 or 1.1, preferably between about 1 and 3, especially about 1.5-2. The time required for extraction decreases with rise in temperature, a short extraction (about 1/2 -3 hours) at a relatively high temperature (about 45 DEG -55 DEG C.) giving the best yields. In examples: (1) (a) an aqueous medium containing soya bean meal, dextrose, meat extract and sodium chloride is incubated with spores of A. griseus at 25 DEG C. and 10-15 lbs. pressure while stirring and passing a current of air; (b) the resulting culture is acidified to pH 3.5 with hydrochloric, agitated at 5 DEG C. and centrifuged, yielding a supernate of enhanced activity; (2) (a) the solid residue from (1) (b) is washed twice with distilled water and then extracted with N/10 hydrochloric acid adjusted to pH2 with sodium hydroxide, centrifuged and the process repeated, the two extracts being used as such (separately or mixed), or added to the liquid product of (1), or treated (together or separately) as follows: (b) the extract is neutralized and its active ingredient purified by adsorption on activated charcoal, elution with dilute hydrochloric acid at 70 DEG C., treatment of the eluate with phosphotungstic acid, decomposition of the precipitated phosphotungstate with barium hydroxide and, if desired, freeze-drying; further purification may be effected by reaction with picnic acid in aqueous solution, dissolving the picrate in acetone, passing the solution through an activated alumina chromatographic adsorption column, eluting the antibiotic-rich sections of the chromatogram with aqueous acetone and decomposing the eluate with sulphuric acid to obtain the sulphate of the antibiotic substance, which may be still further purified by reaction with a Reinecke salt, and decomposing the Reineckate with silver sulphate in aqueous solution; (3) (a) a medium as in (1) (a), but omitting the meat extract, is inoculated with spores and mycelium of A. griseus and similarly incubated; (b) a portion of the resulting culture is treated as in (1) (b) (at 4 DEG C.); (4) (a) the remainder of the product of (3) (a) is centrifuged and the sediment washed and then slurried with distilled water; (b) a portion of the slurry is adjusted to pH 2.08 with 5N hydrochloric acid, shaken at 24 DEG C. (the pH rising to 2.4) and then centrifuged; somewhat inferior results are obtained at pH 1.1-1.22, 3.1-3.9 or 5.0-5.4; (c) the sediment from (b) is again extracted with hydrochloric acid at pH 2.55 (or 5.62 or 1.88); (5) a further portion of the slurry of (4) (a) is adjusted to pH2 with 5N hydrochloric acid, stirred at 50 DEG C. and centrifuged; somewhat inferior results are obtained by longer extractions at 4 DEG C. or 37 DEG C.; (6) a further portion of the slurry of (4) (a) is adjusted to pH 2.15 with 5N sulphuric acid, stirred at 50 DEG C. and centrifuged; the sulphuric acid may be replaced by 40 per cent citric acid; (7) a medium as in (1) (a), except that the percentage of meat extract is halved, is incubated as in (3) (a), and the resulting culture is adjusted to pH 1.5 with 100 per cent sulphuric acid, agitated with the diatomaceous earth filter aid known by the Registered Trade Mark "Celite" and the activated charcoal known as "Nuchar," and centrifuged.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US610570XA | 1945-04-05 | 1945-04-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB610570A true GB610570A (en) | 1948-10-18 |
Family
ID=22033349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB10144/46A Expired GB610570A (en) | 1945-04-05 | 1946-04-02 | Antibiotics |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB610570A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003072564A1 (en) * | 2002-02-27 | 2003-09-04 | Cipla Ltd. | Purification of citalopram |
CN103645151A (en) * | 2013-11-18 | 2014-03-19 | 宁夏泰瑞制药股份有限公司 | Method used for rapid detection of spectinomycin content in spectinomycin broth or finished products |
-
1946
- 1946-04-02 GB GB10144/46A patent/GB610570A/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003072564A1 (en) * | 2002-02-27 | 2003-09-04 | Cipla Ltd. | Purification of citalopram |
CN103645151A (en) * | 2013-11-18 | 2014-03-19 | 宁夏泰瑞制药股份有限公司 | Method used for rapid detection of spectinomycin content in spectinomycin broth or finished products |
CN103645151B (en) * | 2013-11-18 | 2016-06-15 | 宁夏泰瑞制药股份有限公司 | A kind of method of spectinomycin content in quick mensuration spectinomycin fermented liquid or finished product |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2461922A (en) | Antibiotic extraction from solids of actinomyces griseus culture | |
US4051314A (en) | Polysaccharides and method for producing same | |
GB610570A (en) | Antibiotics | |
US2410084A (en) | Recovery of heparin | |
RU94002793A (en) | Method for extraction of dihydroquercitrol | |
SU710503A3 (en) | Method of preparing acetylated water soluble extracts possessing immunostimulating action | |
Hochstein | Alkaloids of Rauwolfia sellowii | |
US2595159A (en) | Preparation of vitamin b12 concentrates from streptomyces griseus cultures | |
US2505053A (en) | Method for recovering grisein | |
US2481267A (en) | Lower aliphatic carboxylic acid salts of streptothricin and streptomycin | |
US2537933A (en) | Preparation of antibiotic salts of mono (higher-aliphatic) sulfates, and purification of the antibiotics thereby | |
US2521770A (en) | Selective carbon adsorption of impurities from acidic streptomycin solutions | |
CA1057114A (en) | Rapeseed protein detoxification and recovery | |
KR0124969B1 (en) | Method for producing acidic polysaccharide from white ginseng | |
RU2110522C1 (en) | Method of preparing the triterpene glycoside sum (variants) | |
US3262854A (en) | Method for the recovery of heparin | |
US1976175A (en) | Process of preparing adenosine phosphoric acid | |
CN107686451B (en) | Preparation method of chestnut skin extract containing ceramide | |
CN107789500B (en) | Preparation method of coumarins in dendrobium candidum | |
US2459139A (en) | Process for extraction and purification of subtilin | |
US2505318A (en) | Recovery and purification of antibiotics | |
US2664419A (en) | Purification of antibiotics | |
Makarevich et al. | Cardiac glycosides of Erysimum crepidifolium | |
JPH07147926A (en) | Method for treating mushroom | |
US3911112A (en) | Antibiotic substances and preparation |